Citation Impact
Citing Papers
Why portal hypertensive varices bleed and bleed: a hypothesis.
1995
UK guidelines on the management of variceal haemorrhage in cirrhotic patients
2015
Stem Cell–Derived Culture Models of Hepatitis E Virus Infection
2018 StandoutNobel
Hepatitis E Virus Mutations: Functional and Clinical Relevance
2016
A Simple Noninvasive Index Can Predict Both Significant Fibrosis and Cirrhosis in Patients With Chronic Hepatitis C
2003 Standout
Pan-Genotype Hepatitis E Virus Replication in Stem Cell–Derived Hepatocellular Systems
2017 StandoutNobel
Hepatitis E virus infection as a cause of graft hepatitis in liver transplant recipients
2009
Prospective Comparison of Spleen and Liver Stiffness by Using Shear-Wave and Transient Elastography for Detection of Portal Hypertension in Cirrhosis
2014
Elastography in Clinical Practice
2014
The long-term benefits of nucleos(t)ide analogs in compensated HBV cirrhotic patients with no or small esophageal varices: A 12-year prospective cohort study
2015
Liver stiffness accurately predicts portal hypertension related complications in patients with chronic liver disease: A prospective study
2011
The neglected hepatitis C virus genotypes 4, 5 and 6: an international consensus report
2009
Study of hepatitis C virus entry in genetically humanized mice
2012 StandoutNobel
Natural history and prognostic indicators of survival in cirrhosis: A systematic review of 118 studies
2005 Standout
Liver stiffness-based optimization of hepatocellular carcinoma risk score in patients with chronic hepatitis B
2013
Hepatocellular carcinoma
2016 Standout
Hepatocellular carcinoma
2018 Standout
Transfusion Strategies for Acute Upper Gastrointestinal Bleeding
2013 Standout
Turning Hepatitis C into a Real Virus
2010 StandoutNobel
Beta-Blockers to Prevent Gastroesophageal Varices in Patients with Cirrhosis
2005
Burden of liver diseases in the world
2018 Standout
Portal hypertension and variceal bleeding: An AASLD single topic symposium†
1998
Natural history of hepatitis C
1997
Acute hepatitis and renal function impairment related to infection by hepatitis E virus in a renal allograft recipient
2005
Measurement of Spleen Stiffness to Evaluate Portal Hypertension and the Presence of Esophageal Varices in Patients With HCV-Related Cirrhosis
2012
Highly Efficient JFH1‐Based Cell‐Culture System for Hepatitis C Virus Genotype 5a: Failure of Homologous Neutralizing‐Antibody Treatment to Control Infection
2008
Prognosis after the First Episode of Gastrointestinal Bleeding or Coma in Cirrhosis: Survival and Prognostic Factors
1989
Expanding consensus in portal hypertension
2015 Standout
Prognostic indicators in alcoholic cirrhotic men
1988
Evaluation of Splanchnic Angiography as a Prognostic Index of Survival in Patients with Cirrhosis
1991
Portal Hypertension in Patients with Liver Cirrhosis: Diagnostic Accuracy of Spleen Stiffness
2015
Early primary prophylaxis with beta-blockers does not prevent the growth of small esophageal varices in cirrhosis: a randomized controlled trial
2012
Incidence and natural history of small esophageal varices in cirrhotic patients
2003
Lack of prognostic usefulness of hepatic venous pressures and hemodynamic values in a select group of patients with severe alcoholic cirrhosis
2002
Non invasive evaluation of portal hypertension using transient elastography
2011
Requirement of Protocol Biopsy Before and After Complete Cessation of Immunosuppression After Liver Transplantation
2009 StandoutNobel
Hepatitis E
2012
Chapter 2 Cutting the Gordian Knot-Development and Biological Relevance of Hepatitis C Virus Cell Culture Systems
2008
Portal hypertensive bleeding in cirrhosis
2016 Standout
Liver-Derived Hepatitis C Virus (HCV)-Specific CD4+ T Cells Recognize Multiple HCV Epitopes and Produce Interferon Gamma
2000 StandoutNobel
Gastroesophageal Variceal Hemorrhage
2001
CD4 T Lymphocyte Proliferative Responses to Hepatitis C Virus (HCV) Antigens in Patients Coinfected with HCV and Human Immunodeficiency Virus Who Responded to Anti‐HCV Treatment
2002 StandoutNobel
Mechanisms of Hepatic Fibrogenesis
2008 Standout
Expanded classification of hepatitis C virus into 7 genotypes and 67 subtypes: Updated criteria and genotype assignment web resource
2013 StandoutNobel
Sofosbuvir Inhibits Hepatitis E Virus Replication In Vitro and Results in an Additive Effect When Combined With Ribavirin
2015 StandoutNobel
Somatostatin Treatment and Risk Stratification by Continuous Portal Pressure Monitoring During Acute Variceal Bleeding
2001
Risk factors for hepatitis E virus infection and disease
2014
Influence of portal hypertension and its early decompression by TIPS placement on the outcome of variceal bleeding
2004
Sequence diversity of hepatitis C virus 6a within the extended interferon sensitivity-determining region correlates with interferon-alpha/ribavirin treatment outcomes
2010
Ledipasvir-sofosbuvir in patients with hepatitis C virus genotype 5 infection: an open-label, multicentre, single-arm, phase 2 study
2016
Assessment of portal hypertension by transient elastography in patients with compensated cirrhosis and potentially resectable liver tumors
2011
Global burden of liver disease: 2023 update
2023 Standout
Hepatitis C virus: How genetic variability affects pathobiology of disease
2011
Real-time shear-wave elastography: Applicability, reliability and accuracy for clinically significant portal hypertension
2014
Magnetic Resonance Imaging More Accurately Classifies Steatosis and Fibrosis in Patients With Nonalcoholic Fatty Liver Disease Than Transient Elastography
2015
UK guidelines on the management of variceal haemorrhage in cirrhotic patients
2000
A placebo-controlled clinical trial of nadolol in the prophylaxis of growth of small esophageal varices in cirrhosis
2004
Liver stiffness measurement selects patients with cirrhosis at risk of bearing large oesophageal varices
2006
Hepatitis E Virus and Chronic Hepatitis in Organ-Transplant Recipients
2008 Standout
Zoonotic hepatitis E: animal reservoirs and emerging risks
2010
Chronic Hepatitis E Virus Infection in Liver Transplant Recipients
2008
The HCV Life Cycle: In vitro Tissue Culture Systems and Therapeutic Targets
2014 Standout
Understanding the hepatitis C virus life cycle paves the way for highly effective therapies
2013 StandoutNobel
A Hepatitis C Virus (HCV) Vaccine Comprising Envelope Glycoproteins gpE1/gpE2 Derived from a Single Isolate Elicits Broad Cross-Genotype Neutralizing Antibodies in Humans
2013 StandoutNobel
Serum bilirubin and platelet count: A simple predictive model for survival in patients with refractory ascites treated by TIPS
2010
Prognostic usefulness of hepatic vein catheterization in patients with cirrhosis and esophageal varices
1992
Hepatitis E
2012
Prognostic value of early measurements of portal pressure in acute variceal bleeding
1999
The epidemiology of hepatitis C infection in the United States
2007
Liver and spleen transient elastography predicts portal hypertension in patients with chronic liver disease: a prospective cohort study
2015
Prognostic variables in patients with cirrhosis and oesophageal varices without prior bleeding
1994
Revising consensus in portal hypertension: Report of the Baveno V consensus workshop on methodology of diagnosis and therapy in portal hypertension
2010 Standout
Elastography, Spleen Size, and Platelet Count Identify Portal Hypertension in Patients With Compensated Cirrhosis
2012
The treatment of portal hypertension: A meta-analytic review
1995
AASLD Practice Guidance on the clinical assessment and management of nonalcoholic fatty liver disease
2023 Standout
EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection
2017 Standout
Hepatitis E Virus Infection
2014
Genetic Analysis of the Carboxy-Terminal Region of the Hepatitis C Virus Core Protein
2009 StandoutNobel
Hepatocellular Carcinoma Incidence, Mortality, and Survival Trends in the United States From 1975 to 2005
2009 Standout
Plasma chemokine levels correlate with the outcome of antiviral therapy in patients with hepatitis C
2005 StandoutNobel
Human broadly neutralizing antibodies to the envelope glycoprotein complex of hepatitis C virus
2012 StandoutNobel
Diverse Hepatitis C Virus Glycoproteins Mediate Viral Infection in a CD81-Dependent Manner
2004 StandoutNobel
Efficient Replication of Genotype 3a and 4a Hepatitis C Virus Replicons in Human Hepatoma Cells
2012 StandoutNobel
Full-length genome sequences of hepatitis C virus subtype 4f
2007
The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases
2017 Standout
Secondary prevention of variceal bleeding in adults with previous oesophageal variceal bleeding due to decompensated liver cirrhosis: a network meta-analysis
2021
Progress towards a hepatitis C virus vaccine
2013 StandoutNobel
Single portal pressure measurement predicts survival in cirrhotic patients with recent bleeding
1999
Quasispecies Heterogeneity within the E1/E2 Region as a Pretreatment Variable during Pegylated Interferon Therapy of Chronic Hepatitis C Virus Infection
2005
Response of Hepatitis C Virus to Long-Term Passage in the Presence of Alpha Interferon: Multiple Mutations and a Common Phenotype
2013 StandoutNobel
Hepatitis E virus in patients with decompensated chronic liver disease: a prospective UK /French study
2015
Viral Determinants of Resistance to Treatment in Patients with Hepatitis C
2007
EASL Recommendations on Treatment of Hepatitis C 2018
2018 Standout
Early changes in hepatitis C viral quasispecies during interferon therapy predict the therapeutic outcome
2002
EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma
2018 Standout
Hepatic Vein Pressure Gradient Reduction and Prevention of Variceal Bleeding in Cirrhosis: A Systematic Review
2006
Antinociceptive action of nitrous oxide is mediated by stimulation of noradrenergic neurons in the brainstem and activation of [alpha]2B adrenoceptors.
2000 StandoutNobel
New Natural Intergenotypic (2/5) Recombinant of Hepatitis C Virus
2007
Turmeric curcumin inhibits entry of all hepatitis C virus genotypes into human liver cells
2013 StandoutNobel
Effectiveness of interferon plus ribavirin combination in the treatment of naive patients with hepatitis C virus type 5. A French multicentre retrospective study
2006
Primary prevention of variceal bleeding in people with oesophageal varices due to liver cirrhosis: a network meta-analysis
2021
Transient elastography: a meta‐analysis of diagnostic accuracy in evaluation of portal hypertension in chronic liver disease
2012
Hepatitis C Virus Genotype 5a Subgenomic Replicons for Evaluation of Direct-Acting Antiviral Agents
2014 StandoutNobel
Ultrasound Elastography: Review of Techniques and Clinical Applications
2017 Standout
EASL Clinical Practice Guidelines for the management of patients with decompensated cirrhosis
2018 Standout
New Methods in Tissue Engineering: Improved Models for Viral Infection
2014 StandoutNobel
Works of J.P. Vinel being referenced
Incidence of large oesophageal varices in patients with cirrhosis: application to prophylaxis of first bleeding.
1990
Transient elastography accurately predicts presence of significant portal hypertension in patients with chronic liver disease
2008
Fulminant liver failure from acute autochthonous hepatitis E in France: description of seven patients with acute hepatitis E and encephalopathy
2007
Hepatitis C Virus Genotype 5: Epidemiological Characteristics and Sensitivity to Combination Therapy with Interferon‐α plus Ribavirin
2004
Pegylated interferon and ribavirin therapy for chronic hepatitis C virus genotype 4 infection
2005
Genetic Heterogeneity of Hypervariable Region 1 of the Hepatitis C Virus (HCV) Genome and Sensitivity of HCV to Alpha Interferon Therapy
2000
Assessment of Short–Term Prognosis After Variceal Bleeding in Patients With Alcoholic Cirrhosis by Early Measurement of Portohepatic Gradient
1986
1067 Acute hepatitis E: a study of 17 consecutive patients in South-West France over a 13 month period
2003